We use cookies to create the best experience for you. Keep on browsing if you are OK with that, or find out how to manage cookies.
Nobody downloaded yet

Tyrosine kinase inhibitors as targeted agents for the treatment of cancer - Dissertation Example

Comments (0)
Summary
Therapeutic advances have been made in the recent past whereby many patients who have had cancers have been able to lengthen the span of their lives through earlier detection and the support of combination therapies or targeted therapies which have evolved through research and clinical trials…
Download full paper
GRAB THE BEST PAPER

Extract of sample
Tyrosine kinase inhibitors as targeted agents for the treatment of cancer

Download file to see previous pages... Therapeutic advances have been made in the recent past whereby many patients who have had cancers have been able to lengthen the span of their lives through earlier detection and the support of combination therapies or targeted therapies which have evolved through research and clinical trials. The chemotherapy targets the kinases involved in the signaling pathways of cancer development. Significant focus has been placed on tyrosine kinases involved in promoting the wild uncontrolled malignant proliferation. The aim of this literature review was to become familiar with possible chemotherapeutic agents employed in the improvement in the quality of life of cancer patients and recognise the possible openings for future research. Introduction Cancer is the abnormal, uncontrolled growth and proliferation of body cells due to a change in the genetic code caused by a mutation occurring when cell structure or specifically DNA is damaged (Dollinger and Rosenbaum, 2008). The incidence of cancer indicates increased rates with 10 million new cases globally every year (Duenas-Gonzalez, 2008). The US alone has 1,368,030 new cancer cases per year. However the mortality rate has been shown to have reduced in some cancers like those of the lung, colorectum, prostate and breast (Duenas-Gonzalez, 2008). The improvement in the 5-year and 10-year survival rates could be due to either early detection or better treatment or both and based on the histopathological type of malignancy. The cytotoxic drugs which were initiated in the pre-genomic era known as the classical drugs or the combination of the traditional cytotoxic drugs with the post-genomic medicines based on rationale (targeted therapies) have not been able to cure the disease yet. The classical drugs were selected for their...
The chemotherapy targets the kinases involved in the signaling pathways of cancer development. Significant focus has been placed on tyrosine kinases involved in promoting the wild uncontrolled malignant proliferation. The aim of this literature review was to become familiar with possible chemotherapeutic agents employed in the improvement in the quality of life of cancer patients and recognise the possible openings for future research.
Cancer is the abnormal, uncontrolled growth and proliferation of body cells due to a change in the genetic code caused by a mutation occurring when cell structure or specifically DNA is damaged (Dollinger and Rosenbaum, 2008). The incidence of cancer indicates increased rates with 10 million new cases globally every year (Duenas-Gonzalez, 2008). The US alone has 1,368,030 new cancer cases per year. However the mortality rate has been shown to have reduced in some cancers like those of the lung, colorectum, prostate and breast (Duenas-Gonzalez, 2008). The improvement in the 5-year and 10-year survival rates could be due to either early detection or better treatment or both and based on the histopathological type of malignancy.
The cytotoxic drugs which were initiated in the pre-genomic era known as the classical drugs or the combination of the traditional cytotoxic drugs with the post-genomic medicines based on rationale (targeted therapies) have not been able to cure the disease yet. The classical drugs were selected for their action in reducing or controlling the tumor. The treatment was based on the difference in cell proliferation in normal and cancer cells (Broekman, 2011). ...Download file to see next pagesRead More
Comments (0)
Click to create a comment
CHECK THESE SAMPLES - THEY ALSO FIT YOUR TOPIC
Morpholins anti-cancer drugs
The target series of compounds was produced through reductive amination between four amines and a dialdehyde produced from α-D-glucopyranose. The amines that were used in the project are: butyl amine, benzyl amine, L-phenylalanine and Tyrosine-OMe.
13 Pages(3250 words)Dissertation
Clinical studies of hormonal treatment approaches to prostate cancer
They perform their functions and ultimately they die. This phenomenon helps the body to stay healthy and functional. However in some cases the cells do not die and instead they keep dividing abnormally creating new cells that is not essential to the body.
15 Pages(3750 words)Dissertation
The Mechanism of Dis2 Phosphorylation by Chk1 and Cell Cycle Regulation
Keywords xiii 4. List of tables xiii 5. List of figures xv Chaper 1 xvii Introduction xvii 1.1. Structure and significance of PP1 xx 1.2. Localization of PP1 xxv 1.3. Catalytic subunits of PP1 (Dis2 and Glc7) and their importance xxvi 1.4. DNA damage response xxix 1.5.
40 Pages(10000 words)Dissertation
Research for practice: Breast cancer
Breast cancer can be identified as a health issue commonly faced by women. However, it can be mentioned that the diagnosis and the treatment of breast cancer had been a part of medical culture since ancient ages which can be dated back to the pyramid age during 3000-2500 BC (Donegan, 2005).
21 Pages(5250 words)Dissertation
Antibody targeted drugs for cancer therapy
Application of monoclonal antibodies for target approach of cancer therapy because of hybridoma technology which has contributed to the production of monoclonal antibodies. Strategies for this therapeutic application are destruction of cancer cells that are directed by immune reaction, interference of the therapy with the growth and differentiation of cancer cells, transport of anti-cancer agents to the cancer cells based on antigen epitopes, anti-idiotype vaccination and finally, development of humanised mouse monoclonal antibodies through genetic engineering.
20 Pages(5000 words)Dissertation
The involvement of ion channels in cancer
Most importantly, the study stresses the progression of cancer, by means of metastasis. After which, the research elaborated the principle of ion channels and its function within the body. It then associates the role that ion channels contribute to the development of cancer cells within the body, and what particular ion channels can be exploited to hinder the growth and proliferation of mutated genes.
20 Pages(5000 words)Dissertation
Tailoring Tyrosine Kinase Inhibitors to Fit the Lung Cancer Genome
(1). Summary Efforts to uncover the genetic basis of cancer have led to the understanding of the importance of critical key tumour suppressors and oncogenes. Additionally, numerous mutations that still need to be characterised have also been uncovered. The marked variations in the mutational profiles however point to every tumor being a distinct state that can be effectively treated with precise targeting of the specific combination of genetic changes that are unique to the tumor.
3 Pages(750 words)Article
Design, synthesis and pharmacological tests of leukotrienes A4 hydrolase inhibitors as a potential targets of interest in cancer
Test in vitro all the synthesized resveratrol derivatives to prove their efficiency as LTA4 hydrolase inhibitors and as novel, promising molecules in cancer treatment. Experimental section General information Flash chromatography was performed using Merck silica gel 60 (230-400 mesh) NMR spectra were obtained at 400 MHz (H1), Bruker AV500 NMR spectrometer in CDCl3.
34 Pages(8500 words)Dissertation
Supporting parents through the experience of their childs cancer treatment
Hence, causing numerous disease-related distress cases both among the ailing and close people whom spent their entire time acting as caregivers (Boman, Bjork & Lindahl, 2003). Mainly, caregivers in this case encompass family members and other close people who normally intervene with the intention of aiding the affected.
32 Pages(8000 words)Dissertation
The use of Beta-blockers and ACE inhibitors or Endothelin receptor antagonist and ACE inhibitors as combination therapy for hear
Selection of Patients for ACE inhibitors and endothelin Receptor Combination 13 Patient Factors to consider when choosing a combined therapy 15 Preference for beta blocker and ACE inhibitor combination therapy over ACE inhibitors and endothelin receptor antagonists combination 16 DISCUSSION 19 The need for a combination therapy 19 Reason for using ACE inhibitors as a constant in both therapies 19 Selection of ACE inhibitors and beta-blocker over ACE inhibitors and Endothelin Receptor antagonists 20 Management of side effects and concomitant therapy 21 CONCLUSIONS 22 Summary 22 Conclusion and Suggestion for future work 23 EXPERIMENTAL 24 References 25 Appendix 27 List of Tables Patient Selecti
24 Pages(6000 words)Dissertation
Let us find you another Dissertation on topic Tyrosine kinase inhibitors as targeted agents for the treatment of cancer for FREE!
Contact us:
+16312120006
Contact Us Now
FREE Mobile Apps:
  • About StudentShare
  • Testimonials
  • FAQ
  • Blog
  • Free Essays
  • New Essays
  • Essays
  • The Newest Essay Topics
  • Index samples by all dates
Join us:
Contact Us